Abilify in Bipolar Disorder for 24 Weeks Treatment Effectiveness

NCT00545675 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

146

Enrollment

INDUSTRY

Sponsor class

Conditions

Bipolar Disorder

Interventions

DRUG: Abilify(aripiprazole)
DRUG: Depakote (divalproate)

Sponsor

Korea Otsuka Pharmaceutical Co., Ltd.